ViCardia Therapeutics, Inc.

ViCardia Therapeutics, Inc.

ViCardia Therapeutics, Inc., a Delaware corporation, founded in 2017, is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapies for treating heart failure (HF) involving mitochondrial dysfunction.

Company details

930 Montgomery Street, Suite 600, San Francisco, California 94133 

Find locations servedoffice locations

Business Type:
Manufacturer
Industry Type:
Pharmaceuticals
Market Focus:
Nationally (across the country)
Year Founded:
2017